302 East Pettigrew St.
About Precision BioSciences
Precision BioSciences is dedicated to improving life through its proprietary genome editing platform, “ARCUS.” Precision BioSciences leverages ARCUS in the development of its product candidates which are designed to treat human diseases and create healthy and sustainable food and agriculture solutions. Precision BioSciences is actively developing product candidates in three innovative areas: allogeneic CAR T immunotherapy, in vivo gene correction, and food.
Precision BioSciences: Culture
131 articles with Precision BioSciences
Cellectis BioResearch European Patent EP 1 485 475 upheld against Precision BioSciences at European Patent Office
Precision BioSciences Announces U.S. Patent Office Reexamination of CELLECTIS SA Patents Involved in Litigation
Precision BioSciences Announces U.S. Patent Office Reexamination of Cellectis Patents Involved in Litigation
Bayer CropScience AG and Precision BioSciences Collaborate to Create Site-Specific Genome Modifications in Plants
Precision BioSciences Issues Update Regarding Recent U.S. Patent Office Action Concerning CELLECTIS SA's Patents
Precision BioSciences Release: US Patent Office Action Rejects Key Claims to CELLECTIS SA' Core Technology
CELLECTIS SA Sues Precision BioSciences for Infringement of Its Patents Concerning Meganuclease Technology